Literature DB >> 16676088

Genetic background and inhibitors in previously untreated or minimally treated young patients with severe haemophilia A treated with sucrose-formulated recombinant factor VIII.

Johannes Oldenburg, Vytautas Ivaskevicius, Jörg Schröder, Clemens R Müller, Arupa Ganguly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16676088

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  1 in total

Review 1.  Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.

Authors:  Jeanne M Lusher; Inge Scharrer
Journal:  Int J Hematol       Date:  2009-11-03       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.